NIH-funded research R21 grant

Investigating how a specific protein affects corneal cell development and health

Official title: Role of transcription factor activating protein-2 beta (AP-2β) in corneal epithelial cell fate determination and stratification

Funded at Mcmaster University · NIH-10683400 · Data updated 2026-11-12

This study is looking at how a specific protein affects the cells in the eye's outer layer, which could help us find better ways to treat eye diseases that can lead to vision loss.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMcmaster University
NIH-funded
Lab location1 site (Hamilton, Canada)
Project startSeptember 1, 2022
Project endAugust 31, 2025
Funding year2023
Award (this year)$148,230
NIH project number5R21EY034241-02
Project IDNIH-10683400 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from corneal diseases or conditions that affect corneal health and vision.

Less likely to help

Patients with corneal conditions unrelated to epithelial cell development or those who do not have access to the research location may not benefit from this research.

What this research studies

This research focuses on understanding the role of the transcription factor activating protein-2 beta (AP-2β) in the development of corneal epithelial cells. By using a mouse model where this protein is specifically deleted in neural crest cells, researchers aim to uncover how this affects corneal structure and function. The study employs advanced techniques such as single-cell RNA sequencing and immunohistochemistry to analyze changes in corneal cell types and markers. The ultimate goal is to identify mechanisms that could lead to improved treatments for corneal diseases that can cause vision loss.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating corneal pathologies and preventing blindness.

How similar studies have gone: While the specific role of AP-2β in corneal epithelial development is not well-studied, similar approaches in understanding transcription factors have shown promise in other areas of regenerative medicine.

Where this research is happening

  • Mcmaster University
    Hamilton, Canada
    Active

Researchers

  • Principal investigator: West-Mays, Judith a — Mcmaster University
  • Study coordinator: West-Mays, Judith a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.